^
    Apply
    Study of LVGN7409 (CD40 Agonist Antibody) in Locally Advanced, Metastatic or Recurrent/Refractory Malignancy (NCT05152212)
    Phase 1
    Lyvgen Biopharma Holdings Limited
    Completed
    Last update posted :
    04/19/2024
    Initiation :
    09/29/2021
    Primary completion :
    12/06/2023
    Completion :
    12/06/2023
    CD4
    |
    dalnicastobart (LVGN7409)
    Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors (NCT05075993)
    Phase 1
    M.D. Anderson Cancer Center
    Recruiting
    Last update posted :
    04/04/2024
    Initiation :
    11/12/2021
    Primary completion :
    02/02/2027
    Completion :
    02/02/2027
    CD40
    |
    Avastin (bevacizumab) • albumin-bound paclitaxel • cyclophosphamide • cyclophosphamide intravenous • dalnicastobart (LVGN7409) • exlinkibart (LVGN6051) • pradusinstobart (LVGN3616)